About Biospectal
Biospectal is a company based in Lausanne (Switzerland) founded in 2017 by Patrick Schoettker. Biospectal has raised $4.3 million across 1 funding round from investors including LabCorp, Seedlink and Athensmed. Biospectal offers products and services including OptiBP. Biospectal operates in a competitive market with competitors including iHealth Labs, Aktiia, Oxehealth, Vectorious Medical Tech and EarlySense, among others.
- Headquarter Lausanne, Switzerland
- Founders Patrick Schoettker
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biospectal Sa
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.3 M (USD)
in 1 rounds
-
Latest Funding Round
$4.3 M (USD), Seed
Jul 21, 2021
-
Investors
LabCorp
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biospectal
Biospectal offers a comprehensive portfolio of products and services, including OptiBP.
AI-driven tool for measuring blood pressure via smartphone camera.
People of Biospectal
Unlock access to complete
Unlock access to complete
Funding Insights of Biospectal
Biospectal has successfully raised a total of $4.3M through 1 strategic funding round. The most recent funding activity was a Seed round of $4.3 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biospectal
Biospectal has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, Seedlink and Athensmed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Seed and early-stage startups are invested in by Privilege Ventures.
|
Locked | Locked | Locked |
Investor details for Biospectal
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biospectal
Investment portfolio details for Biospectal
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biospectal
Detailed financials for Biospectal
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biospectal Comparisons
Peer comparison for Biospectal
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biospectal
Biospectal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iHealth Labs, Aktiia, Oxehealth, Vectorious Medical Tech and EarlySense, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Personal healthcare devices for vital monitoring are designed and produced.
|
|
| Locked | Locked | Locked |
Offers wearable technology for 24/7 blood pressure tracking and app-based data analysis.
|
|
| Locked | Locked | Locked |
Contactless patient monitoring is provided for mental health facilities.
|
|
| Locked | Locked | Locked |
Miniature wireless implant for left atrial pressure monitoring is provided.
|
|
| Locked | Locked | Locked |
Develops innovative smart devices for cardiac health monitoring.
|
Detailed competitors of Biospectal
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biospectal
Complete news archive for Biospectal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biospectal
Biospectal was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Biospectal is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Eliott Jones is the current CEO of Biospectal.
Biospectal is a funded company, having raised a total of $4.3M across 1 funding round to date.
Biospectal was founded in 2017 in Lausanne, Switzerland, within the health technology sector. An app-based platform is provided for blood pressure monitoring and management. Optical analysis is performed using smartphone cameras to measure blood pressure through fingertip placement. Operations focus on non-invasive health metrics, with services accessible via mobile devices in various regions.
Biospectal's top competitors include iHealth Labs, Oxehealth and Riva Health.
Biospectal offers OptiBP.
Biospectal has 4 investors. Key investors include LabCorp, Seedlink, Athensmed, and Privilege Ventures.